Skip to content

A Study on the Efficacy and Safety of Multi-focal Scleral Contact Lens

A Multicenter Randomized Controlled Study on the Efficacy and Safety of Multi-focal Scleral Contact Lens in the Treatment of Ultra-high Myopia in Children and Adolescents

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05533450
Enrollment
150
Registered
2022-09-09
Start date
2022-10-18
Completion date
2024-11-30
Last updated
2022-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Myopia

Keywords

high myopia, children and adolescents, defocus, scleral contact lens

Brief summary

The rigid scleral contact lens with optical multi-focal design adopted in this study can focus the light in part of the optical area on the front of the retina to form myopic defocus, in order to delay the axial changes in children and adolescents with ultra-high myopia. In this study, RGP was used as a control, and a multicenter, randomized, controlled trial was conducted to verify the safety and effectiveness of multifocal scleral contact lenses for the correction of ultra-high myopia in children and adolescents.

Interventions

DEVICEMulti-focal rigid scleral contact lens

True scleral lenses rest on the sclera and do not touch the cornea and limbus, leaving a clear area between the contact lens and the cornea.

DEVICERigid gas permeable contact lens

RGP contact lens is designed from a special rigid hydrophobic material. Patients wear RGP contact lens to form a contact lens-tear-cornea system to correct irregular astigmatism, reduce aberrations, provide good visual quality, and control the development of the disease through mild shaping effect.

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Shandong University of Traditional Chinese Medicine
CollaboratorOTHER
Shanghai Eye Disease Prevention and Treatment Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

1. Be able to understand and sign the informed consent when accompanied by parents or guardians. 2. Age from 8 years old to15 years old. 3. The equivalent spherical lens of both eyes after ciliary muscle paralysis is -5.00D to -20.00D, the astigmatism is ≤-3.50D. 4. Willing to wear hard contact lenses, and able to wear only the hard contact lenses provided by the study as required and ensure adequate wearing duration. (6) Best corrected visual acuity of both eyes ≥ 0.8.

Exclusion criteria

(1) Allergic or intolerant to rigid contact lens or its care products or ciliary muscle paralysis drugs. Strabismus and/or amblyopia. (3) Those who have worn hard contact lenses in the past 30 days are using atropine, defocus frame lens, bifocal lens or progressive lens, acupuncture, etc. for myopia treatment. (4) Any clinically significant active eye disease, such as glaucoma, uveitis, chorioretinitis, central retinal artery or vein occlusion, and so on. (5) Patients with systemic diseases that may affect the wearing of hard contact lenses, such as hyperthyroidism, diabetes, mental illness, and so on. (6) are using drugs that affect their eye health. (7) History of eye injury or surgery. (8) Incapacitated or unable to follow the visitor as required. (9) Other conditions not suitable for inclusion as judged by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Axial length2 yearsTwo-year change in axial length

Secondary

MeasureTime frameDescription
changes of spherical equivalent2 yearsSpherical equivalent as measured by cycloplegia autorefraction

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026